These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 33224571)

  • 1. Promising preventive and therapeutic effects of TaibUVID nutritional supplements for COVID-19 pandemic: towards better public prophylaxis and treatment (A retrospective study).
    El Sayed SM; Aboonq MS; El Rashedy AG; Aljehani YT; Abou El-Magd RM; Okashah AM; El-Anzi ME; Alharbi MB; El-Tahlawi R; Nabo MMH; Yousef RS; Elshazley M; Abu-Elnaga M; Mahmoud HS; El-Alaf H; Abdelrahman AI; Abdel-Gawad AR; Soliman TM
    Am J Blood Res; 2020; 10(5):266-282. PubMed ID: 33224571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TaibUVID nutritional supplements help rapid cure of COVID-19 infection and rapid reversion to negative nasopharyngeal swab PCR: for better public prophylaxis and treatment of COVID-19 pandemic.
    El Sayed SM; Aboonq MS; Aljehani YT; Hassan MA; Abou El-Magd RM; Abdelrahman AI; El-Tahlawi R; Nabo MMH; Yousef RS; Mahmoud AA; Elsayed YY; Abu-Elnaga M; Soliman TM; Abdel-Gawad AR; Elshazley M; Baghdadi H; El-Sawy S; Mahmoud HS; El-Anzi ME; Alharbi MB
    Am J Blood Res; 2020; 10(6):397-406. PubMed ID: 33489449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial.
    Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G
    Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nigella sativa supplementation to treat symptomatic mild COVID-19: A structured summary of a protocol for a randomised, controlled, clinical trial.
    Koshak AE; Koshak EA; Mobeireek AF; Badawi MA; Wali SO; Malibary HM; Atwah AF; Alhamdan MM; Almalki RA; Madani TA
    Trials; 2020 Aug; 21(1):703. PubMed ID: 32771034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.
    Dixon BE; Wools-Kaloustian K; Fadel WF; Duszynski TJ; Yiannoutsos C; Halverson PK; Menachemi N
    medRxiv; 2020 Oct; ():. PubMed ID: 33106813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Active Compounds of Nigella sativa in COVID-19: A Narrative Review.
    H U; S M; A A; Pk M; R K; R D; D S; Aa M; Panda PK
    Recent Adv Antiinfect Drug Discov; 2023 Feb; ():. PubMed ID: 36815641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting pharmacological potentials of Nigella sativa seed: A promising option for COVID-19 prevention and cure.
    Islam MN; Hossain KS; Sarker PP; Ferdous J; Hannan MA; Rahman MM; Chu DT; Uddin MJ
    Phytother Res; 2021 Mar; 35(3):1329-1344. PubMed ID: 33047412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
    Barnabas RV; Brown E; Bershteyn A; Miller RS; Wener M; Celum C; Wald A; Chu H; Wesche D; Baeten JM;
    Trials; 2020 Jun; 21(1):475. PubMed ID: 32493478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a randomised controlled trial.
    Ashraf S; Ashraf S; Akmal R; Ashraf M; Kalsoom L; Maqsood A; Imran MA; Farooq I; Ashraf S; Siddiqui UN; Ghufran M; Akram MK; Majeed N; Rafique S; Habib Z; Shahab MS; Akmal A; Shaukat Z; Abdin ZU; Khaqan A; Arshad S; Rehman Virk MA; Gul M; Awais AB; Hassan M; Khalid N; Iqbal QUA; Ahmad T; Akram M; Muhammad A; Khalil M; Aslam A; Umer M; Sherazi SSH; Safdar Z; Ahmad S; Bilal M; Zahid MN; Koshak AE; Hilal A; Malik AA; Iqbal U; Baig AA; Alahmadi YM; Humayun A; Malik A; Ahmad A; Ashraf M; Saboor QA; Izhar M;
    Trials; 2021 Sep; 22(1):618. PubMed ID: 34526081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swab and Sputum SARS-CoV-2 RNA-Negative, CT-Positive, Symptomatic Contacts of COVID-19 Cases: A Hypothesis-Generating Prospective Population-Based Cohort Study of Eight Clusters.
    Huang L; Zhang X; Zhang L; Xu J; Wei Z; Xu Y; Zhang C; Xu A
    Front Med (Lausanne); 2021; 8():685544. PubMed ID: 34485329
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential role of
    Shirvani H; Rostamkhani F; Arabzadeh E; Mohammadi F; Mohammadi F
    Sport Sci Health; 2021; 17(4):849-854. PubMed ID: 34093778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multicenter placebo-controlled randomized clinical trial.
    Ashraf S; Ashraf S; Ashraf M; Imran MA; Kalsoom L; Siddiqui UN; Farooq I; Akmal R; Akram MK; Ashraf S; Ghufran M; Majeed N; Habib Z; Rafique S; -Abdin ZU; Arshad S; Shahab MS; Ahmad S; Zheng H; Mirza AR; Zulfiqar S; Anwar MI; Humayun A; Mahmud T; Saboor QA; Ahmad A; Ashraf M; Izhar M;
    Phytother Res; 2023 Feb; 37(2):627-644. PubMed ID: 36420866
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 26.